Related Experiment Video

Updated: Jan 9, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.1K

Specific atrophy patterns distinguish tau and TDP-43 pathology: a longitudinal MRI ante-mortem study

Yasmine Salman1, Julia Goloubeva2, Lara Huyghe2

  • 1Institute of Neuroscience, UCLouvain, Brussels, Belgium. yasmine.salman@uclouvain.be.

Acta Neuropathologica Communications
|December 9, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Alzheimer’s diseaseAntemortem MRIAtrophy patternsLimbic-predominent age related TDP-43 EncephalopathyTDP-43Tau

More Related Videos

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

761
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.5K

Related Experiment Videos

Last Updated: Jan 9, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.1K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

761
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.5K

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

Articles linked to this work by shared authors, journal, and citation graph.

Biomarker-Based Diagnosis and Care Pathways for Alzheimer's Disease in the Era of Disease-Modifying Treatments: A Consensus Statement by Belgian Experts.

European journal of neurology·2026

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

JAMA·2026

Volumetric postmortem MRI of the medial temporal lobe in Alzheimer's disease and related disorders: methodological advances and implications for in vivo biomarker development.

NeuroImage·2026

Olfactory decline tracks central-to-peripheral spread of tau pathology in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Tau pathological activity in plasma before the onset of symptomatic Alzheimer's disease.

medRxiv : the preprint server for health sciences·2026

Baseline cortical amyloid-β levels are associated with subsequent study-partner-rated apathy in community-dwelling older adults.

Journal of Alzheimer's disease : JAD·2026

Overactivation of SHH signaling induces a cascade of dedifferentiation and oncogenesis in a new mouse model for choroid plexus carcinoma.

Acta neuropathologica communications·2026

Immune niches in brain tumors: glial-immune cell interactions and spatial microdomains.

Acta neuropathologica communications·2026

Amplification of seeding-competent tau aggregates by PMCA in human and experimental tauopathies.

Acta neuropathologica communications·2026

Overactive EAAT1 Cl- channels impair GABAergic tonic inhibition in SLC1A3-associated episodic ataxia.

Acta neuropathologica communications·2026

Galectin-3 is elevated in Müller glia in human glaucomatous eyes and ocular hypertensive rat eyes and associated with phagocytosing states.

Acta neuropathologica communications·2026

Time-dependent prognostic value of automated Ki67 assessment and its integration with molecular risk profiling in WHO grade 2 meningioma.

Acta neuropathologica communications·2026

Describing Candidate Geographic Atrophy Phenotypes and Their Different Growth Parameters.

American journal of ophthalmology·2026

Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras.

The Journal of rheumatology·2026

Ancient genomes reveal distinct human dispersals and social stratification in the settlement history of western Remote Oceania.

Cell·2026

[Characteristics and individual mortality burden of functional dependency, cognitive impairment, and depressive symptoms among older adults in China].

Zhonghua yi xue za zhi·2026

Lasting effects of redlining: The association of historical redlining and cognitive function in older Black adults.

Social science & medicine (1982)·2026

Long-term endoscopic evolution from early findings to typical features in autoimmune gastritis: a retrospective study.

Scandinavian journal of gastroenterology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us